Résultat de recherche

Innate immune cells, major actors of sickle cell disease pathophysiology.

Olivier Hermine, Thiago Trovati Maciel

Source :

Pmid / DOI:

A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.

Olivier Hermine, Thiago Trovati Maciel

Source :

Pmid / DOI:

Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin.

Francine Côté, Olivier Hermine

Source :

Pmid / DOI:

FAS and RAS related Apoptosis defects: From autoimmunity to leukemia.

Frédéric Rieux-Laucat

Source :

Pmid / DOI:

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Frédéric Rieux-Laucat

Source :

Pmid / DOI:

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

Frédéric Rieux-Laucat

Source :

Pmid / DOI:

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Source :

Pmid / DOI:

Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.

Source :

Pmid / DOI:

Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency.

Alain Fischer

Source :

Pmid / DOI:

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.

Frédéric Rieux-Laucat

Source :

Pmid / DOI:

Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy.

Nadine CERF-BENSUSSAN

Source :

Pmid / DOI: